ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Scientist I, Cheminformatics at Eikon Therapeutics - ApplyBlast

Senior Scientist I, Cheminformatics

Eikon Therapeutics

6 days ago

3.3 on Glassdoor

Millbrae, California, United States

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Eikon Therapeutics is seeking a Senior Scientist I, Cheminformatics to apply cheminformatics and machine learning technologies to drive drug discovery programs. The role involves collaborating with cross-functional teams to analyze assay and structure-activity data, develop predictive models, and optimize data pipelines for chemical structures. This position aims to accelerate the drug discovery process and contribute to the development of novel treatments for life-threatening diseases.

Responsibilities

Develop and apply cheminformatics data-mining algorithms for molecular modeling and virtual screening
Process and analyze chemical and biological datasets to evaluate drug-likeness and ADMET properties
Optimize data pipelines for processing and storing chemical structures using cheminformatics toolkits

Skills

About Eikon Therapeutics

eikontx.com

Headquarters

Millbrae, California, United States

Company Size

201-500 employees

Founded

2019

View Profile

Eikon Therapeutics is a biotechnology company that advances breakthrough therapeutics through the purposeful integration of science and engineering. The company has built a proprietary discovery platform that combines high‑resolution structural and single‑particle imaging (including cryo‑EM), automated experimental engineering, and computational/AI methods to map protein conformational landscapes and identify novel small‑molecule modulators. That platform is used to accelerate target identification, structure‑enabled design, and lead optimization across multiple therapeutic areas through internal programs and external partnerships. Headquartered in Cambridge, MA, Eikon emphasizes an engineering‑first approach to tackle challenging protein targets and shorten drug discovery timelines.